Publikasi

Lilly to Acquire Kelonia for Up to $7B, Expanding Cance...

Kelonia’s lead program KLN-1010 is a one-time intravenous gene therapy designed ...

Synthetic Biology and Tissue Engineering Grow Liver Tis...

Using engineered liver tissue as a proof-of-concept application, researchers int...

Choosing the Right Orthopedist in NYC: A Guide to Top-R...

Key Takeaways Choosing the right orthopedist in NYC is a critical decision […] T...

Top-Rated Knee Replacement Hardware in NYC: A Guide to ...

Key Takeaways Choosing durable knee replacement hardware is crucial for long-ter...

Tennessee Lawmakers Approve $311 Million for New UT Hea...

State lawmakers have approved $311 million in funding for a new College of Medic...

AACR 2026: Cancers of Unknown Primary Identified by DNA...

By analyzing CpG-based DNA methylation, researchers from Kindai University in Ja...

Improving Patient Experience Starts with How Teams Co...

Healthcare teams are being asked to do more with less. Staffing shortages, risin...

Comparing Knee Replacement Materials: A Patient’s Guide...

Key Takeaways Knee implants are typically made from metal alloys, advanced polye...

The Orthopedic Surgery Center of Green Bay receives its...

We are excited to announce and share that the OSMS Orthopedic Surgery Center of ...

Multidisciplinary care: dental therapy in a hospital se...

Dental therapist Rhianna Clarke shares how her varied roles in hospital, practic...

Colossal Biosciences said it cloned red wolves. Is it f...

If you want to capture something wolflike, it’s best to embark before dawn. So o...

Decoding Resistance to Targeted Therapy via New Cancer ...

Developing resistant models directly from patient tumors can take years due to s...

UCB to purchase Neurona and NRTX-1001 for $1.15bn

The deal value comprises an upfront payment of up to $650m and up to $500m in fu...

BIO kicks off ‘Fight of Our Lives,’ highlighting urgenc...

As biotech celebrates its 50th year, we are locked in “the fight of our lives” t...

MSD secures EC approval for Enflonsia to prevent infant...

This approval authorises Enflonsia’s marketing across all 27 European Union memb...

Clinical exclusivity for indigenous medicines can impro...

Nikkhil Masurkar, CEO, Entod Pharmaceuticals opines that in the absence of clin...